[Changes in respiration, glucose consumption and glycolysis of leukocytes during therapy with alkylating agents (1,4-dimethansulfonoxybutane and 2,4,-triethylenimino-1,3,5-triazine or TEM)].
D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism*; D006019:Glycolysis; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007962:Leukocytes / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism*; D014265:Triethylenemelamine / Q000627:therapeutic use
D000477:Alkylating Agents; D014265:Triethylenemelamine; D002066:Busulfan; D005947:Glucose; D010100:Oxygen
Modificazioni della respirazione, del consumo di glucosio e della glicolisi dei leucociti durante terapia con agenti alchilanti (1,4-dimetansulfonossibutano e 2,4,6-trietilentimino-1,3,5-triazina o TEM.